SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' reply

Affiliations

¹ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jychang@mdanderson.org.
² Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁴ Department of Cardiovascular and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Comment

Joe Y Chang et al. Lancet Oncol. 2021 Dec.

. 2021 Dec;22(12):e537-e538.

doi: 10.1016/S1470-2045(21)00668-9.

¹ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jychang@mdanderson.org.
² Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁴ Department of Cardiovascular and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

No abstract available

Comment in

SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
Kashihara T. Kashihara T. Lancet Oncol. 2021 Dec;22(12):e534. doi: 10.1016/S1470-2045(21)00594-5. Lancet Oncol. 2021. PMID: 34856144 No abstract available.
SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
Luo MS. Luo MS. Lancet Oncol. 2021 Dec;22(12):e535. doi: 10.1016/S1470-2045(21)00632-X. Lancet Oncol. 2021. PMID: 34856145 No abstract available.
SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
Zhang J, Liu L, Zhao K, Guo C, Li S. Zhang J, et al. Lancet Oncol. 2021 Dec;22(12):e536. doi: 10.1016/S1470-2045(21)00656-2. Lancet Oncol. 2021. PMID: 34856146 No abstract available.

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA; STARS Lung Cancer Trials Group. Chang JY, et al. Lancet Oncol. 2021 Oct;22(10):1448-1457. doi: 10.1016/S1470-2045(21)00401-0. Epub 2021 Sep 13. Lancet Oncol. 2021. PMID: 34529930 Free PMC article. Clinical Trial.